A Study of AK127 Combined With AK104 in Patients With Advanced Malignant Tumors
Status:
Not yet recruiting
Trial end date:
2026-02-01
Target enrollment:
Participant gender:
Summary
A Phase Ia/Ib open label，clinical study evaluating the safety, tolerability and preliminary
efficacy of AK127 in combination with AK104 in patients with advanced malignant tumors